ABSI
Price
$4.96
Change
-$0.23 (-4.43%)
Updated
Feb 21 closing price
Capitalization
569.68M
24 days until earnings call
IMNM
Price
$9.52
Change
-$0.59 (-5.84%)
Updated
Feb 21 closing price
Capitalization
806.11M
31 days until earnings call
Ad is loading...

ABSI vs IMNM

Header iconABSI vs IMNM Comparison
Open Charts ABSI vs IMNMBanner chart's image
Absci
Price$4.96
Change-$0.23 (-4.43%)
Volume$4.97M
Capitalization569.68M
Immunome
Price$9.52
Change-$0.59 (-5.84%)
Volume$674.08K
Capitalization806.11M
ABSI vs IMNM Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. IMNM commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and IMNM is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ABSI: $4.96 vs. IMNM: $9.52)
Brand notoriety: ABSI and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 83% vs. IMNM: 67%
Market capitalization -- ABSI: $569.68M vs. IMNM: $806.11M
ABSI [@Biotechnology] is valued at $569.68M. IMNM’s [@Biotechnology] market capitalization is $806.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, ABSI is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 6 TA indicator(s) are bullish while IMNM’s TA Score has 3 bullish TA indicator(s).

  • ABSI’s TA Score: 6 bullish, 4 bearish.
  • IMNM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ABSI is a better buy in the short-term than IMNM.

Price Growth

ABSI (@Biotechnology) experienced а -14.78% price change this week, while IMNM (@Biotechnology) price change was -8.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

ABSI is expected to report earnings on May 20, 2025.

IMNM is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($806M) has a higher market cap than ABSI($570M). ABSI YTD gains are higher at: 89.313 vs. IMNM (-10.358). ABSI has higher annual earnings (EBITDA): -83.27M vs. IMNM (-109.95M). IMNM has more cash in the bank: 240M vs. ABSI (127M). IMNM has less debt than ABSI: IMNM (2.72M) vs ABSI (12M). IMNM has higher revenues than ABSI: IMNM (10.1M) vs ABSI (4.21M).
ABSIIMNMABSI / IMNM
Capitalization570M806M71%
EBITDA-83.27M-109.95M76%
Gain YTD89.313-10.358-862%
P/E RatioN/AN/A-
Revenue4.21M10.1M42%
Total Cash127M240M53%
Total Debt12M2.72M441%
TECHNICAL ANALYSIS
Technical Analysis
ABSIIMNM
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 6 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
89%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STEYX13.75-0.11
-0.79%
AB International Strat Eqs Adv
JGERX12.29-0.14
-1.13%
JHancock Global Equity R2
PMJAX10.52-0.32
-2.95%
PIMCO RAE US Small A
ZSCCX29.90-1.01
-3.27%
Zacks Small-Cap Core Inv
ADNAX16.08-0.98
-5.74%
American Beacon ARK Transfmt Innov A

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with BEAM. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
-4.43%
BEAM - ABSI
50%
Loosely correlated
-8.18%
CRSP - ABSI
50%
Loosely correlated
-5.00%
ABCL - ABSI
50%
Loosely correlated
-3.50%
RXRX - ABSI
48%
Loosely correlated
-10.34%
IMNM - ABSI
46%
Loosely correlated
-5.84%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-5.84%
KYMR - IMNM
49%
Loosely correlated
-1.63%
IDYA - IMNM
49%
Loosely correlated
+0.55%
FATE - IMNM
48%
Loosely correlated
-8.09%
RXRX - IMNM
47%
Loosely correlated
-10.34%
BEAM - IMNM
47%
Loosely correlated
-8.18%
More